Member Info for Mozax

And the 25th largest Company in the World by MCap.

And Johnson & Johnson have partnered with us, little old Trellus Health.

Interestingly, the update today stated a healthy cash position, licensing agreements with pharmaceutical industry partners AND highlighted the potential VALUE of the Company’s proprietary resilience-based platform, programs and assessments to pharma clients.

It also stated that it was preparing to Launch the program with J&J after finalising preparations- this income, which is confidential, is not included in todays update.

So, a few sold and as per usual & the MM’s stirred it up posting a nice big red drop by increasing the spread, but actually it was a really good update, nice and clear and not Rampy, with some good facts such as a 89% increase in resilience-associated behaviour on completion of the program - that, in anyone’s book, is extremely positive.

I can see a decent blue close today when these facts actually filter through.

4.6M Volume so expect TR1 - about to take off.

Well put Manifesto.

It might start to dawn on peeps that J&J is a $400 Billion Dollar Company, and our agreement with them is NOT exclusive.

Chartists May also agree that a re-test of 5p is not far away, and I suspect existing holders may use this dip to top up ahead of traders who may find this coming onto their radars, pesky as they are.

I’m rather looking forward to further agreements being announced of a similar calibre, then see where this starts to re-settle.

The agreement with J&J validates The Trellus platform on a Global Scale, a partnership with such a giant healthcare corporation not only provides a tremendous opportunity but also establishes Trellus as a significant player in this area.

Numerous small AIM listed Companies vie for the opportunity to expand with partnerships such as this, and I suspect the potential is gradually filtering into the market as investors begin to build positions here.

Significant Shareholders such as Icahn School of Medicine hold substantial interest as do the CEO and other Board members, always a positive sign.

With such low freefloat it’s volatile but the longer term potential could provide very significant returns imo.

£1M raised at 2p by new quality investors which was at a significant discount at the time.

The Business is now cash positive without any debt, and highly scalable.

It will be interesting to see at what point buyers come back in, and a quick reversal will be in play, I’m certainly starting to get interested in adding a tranche soon.

XTP holding steady, once TAP sort GBP and USD loading directly to the card plus Apple Pay then I think XTP will take off, as holders make the most of up to 8% cash back when locking XTP.

It’s the rapid Global scalability of the platform that gives TAP multi-bagging potential.

L2 suggests boom time….

I’ve considered the fact that whilst the J&J figures remain undisclosed to the general market, there are plenty of insiders that have all the details.

And this Company is extraordinarily cheap atm…..

Back in 2021…..watch this space

Current MCap £4.5M

And an agreement announced with a Global Health care giant…..

Yes, it was very oversold from the Johnson & Johnson announcement when 5p was being paid, current MCap at 2.5p is a measly £4M.

Can’t buy……

Imagine if Trellus announce another Global Pharma offering their program…..

I note Ichann School of Medicine hold 25% of the stock here

Big bounce on, up 31.43% in about 5 mins!!!!

Somethings afoot…….up 16.2%

Presumably what we are seeing is the end of the placing shares as they are now all tucked away with new investors.

Proper market dynamics are now in force and with the Global rollout of this incredible technology investors are looking for potentially serious returns from these remarkably low levels.

I see this as a very easy long term hold.

Yes, agreed - solid block buying going on atm and MM’s have the book in ‘stealth mode’, so L2 isn’t attractive to the traders whilst the orders are being filled.

I expect further TR1’s soon.

Indeed, 60% retrace since Johnson & Johnson announcement suggests somewhat oversold.

Last handful at 2.1p available.

Delayed print of 500K trade at 2.05p

A probable blue finish imo.

Buyers at 2p. Me.

Once our seller is out this will re-rate very rapidly imo.

Odd trading pattern imo, over 3 Million traded in first 2 hours , and plenty of “unknown” trades….smoke & mirrors phase.

I’ve seen this plenty of times where big investors deliberately hold down a stock to bore the impatient to sell up and in the meantime accumulate their shares.

The Newlands have a formidable stock picking record so that should create some confidence for LTH’s.

Someone’s woken up with their finger on the sell button…..TR1 soon, let’s see who’s picking them up.

And the Market is catching on…….

"In some nine weeks (including the Christmas break), and less than 1000m of drilling, we have moved Pepas from a concept to one of the most exciting exploration stories in the gold space.”